Monitoring of Interobserver Agreement in Nuclear Atypia Scoring of Node-negative Breast Carcinomas Judged at Individual Collaborating Hospitals in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Protocol
Authors:
Open Access
- 1 September 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 29 (9) , 413-420
Abstract
Background: In the NSAS-BC protocol, the nuclear atypia and mitotic counts are to be judged by pathologists at each participating hospital for assessing high-risk node-negative breast cancers. Therefore, maintenance of interobserver agreement in diagnosis at a higher level is mandatory during the period of patient entry. Methods: Individual collaborating pathologists originally evaluated the histological eligibility of 107 cases. Three panel pathologists determined consensus diagnoses and 29–37 collaborating pathologists determined modal diagnoses of these cases at three slide conference sessions. The original diagnoses were compared with the consensus and modal diagnoses to estimate the percentage of erroneous judgments. Results: The agreement rate in histological type and nuclear atypia score was 69% (74/107) between the original and consensus diagnoses, 76% (81/107) between the original and modal diagnoses and 86% (92/107) between the consensus and modal diagnoses. The strength of interobserver agreement at the slide conference sessions was moderate (0.447–0.535) by κ statistics. The original, consensus and modal diagnoses were concordant in 71 cases (66%), but were discordant in 36. Of 35 invasive ductal carcinomas with discordant diagnoses, the discordance arose from the intermediate tumor nature in 15, multiple factors in 13 and erroneous diagnosis in seven (6.5%), if the characteristics of the tumor were judged from the percentage interobserver agreement per tumor at the slide conferences. Conclusion: Nuclear atypia scoring given at individual hospitals on case entry was almost reproducible among the pathologists. Continuous efforts are needed to improve interobserver agreement and to decrease erroneous diagnosis for protocol eligibility.Keywords
This publication has 10 references indexed in Scilit:
- The Efficacy and Limitations of Repeated Slide Conferences for Improving Interobserver Agreement When Judging Nuclear Atypia of Breast CancerJapanese Journal of Clinical Oncology, 1999
- Establishment of Histological Criteria for High-risk Node-negative Breast Carcinoma for a Multi-institutional Randomized Clinical Trial of Adjuvant TherapyJapanese Journal of Clinical Oncology, 1998
- Phase III Randomized Comparison of Postoperative Adjuvant Chemotherapy with 2-Year Oral UFT (Uracil/Tegafur) versus Six-Cycle CMF (Cyclophosphamide/Methotrexate/5-Fluorouracil) in High-risk Node-Negative Breast Cancer PatientsJapanese Journal of Clinical Oncology, 1998
- Histologic Grading of Breast Cancer:Let’s Do ItAmerican Journal of Clinical Pathology, 1995
- Interobserver Reproducibility of the Nottingham Modification of the Bloom and Richardson Histologic Grading Scheme for Infiltrating Ductal CarcinomaAmerican Journal of Clinical Pathology, 1995
- Histologic grading of breast carcinoma. A reproducibility studyCancer, 1994
- Histological grading in breast cancer: interobserver agreement, and relation to other prognostic factors including ploidyPathology, 1992
- Comment on ‘Interobserver reproducibility of histopathological features in Stage II breast cancer’, by KW Gilchrist et al.Breast Cancer Research and Treatment, 1985
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977
- Measuring nominal scale agreement among many raters.Psychological Bulletin, 1971